Prices of essential medicines set to see a hike
About NPPA
- The National Pharmaceutical Pricing Authority was established in 1997 as an independent body of experts to regulate the pricing of drugs.
- It has been constituted as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers.
- The Authority has been entrusted with the task of
- Fixation/revision of prices of pharmaceutical products (bulk drugs and formulations),
- Enforcement of provisions of the Drugs (Prices Control) Order (DPCO).
- Monitoring of the prices of controlled and decontrolled drugs in the country.
- The NPPA currently fixes prices of drugs placed in the National List of Essential Medicines (NLEM) under Schedule-I of the DPCO.
- Non-scheduled drugs are allowed an increase of up to 10 per cent in prices every year, which is monitored by the NPPA.
- NPPA can also fix the price for non-scheduled drugs by invoking extraordinary powers in public interest, under the Drugs (Prices Control) Order, 2013.
Why in News?
-
- Prices of 384 essential drugs and over 1,000 formulations are set to see a hike of over 11%, due to a sharp rise in the Wholesale Price Index (WPI).
- Annual hikes in the prices of drugs listed in the National List of Essential Medicines (NLEM) are based on the WPI.
- The National Pharmaceutical Pricing Authority said the annual change in WPI was 12.12% for the calendar year 2022. Last year, the National Pharmaceutical Pricing Authority (NPPA) announced a 10.7% change in the Wholesale Price Index (WPI).
- Every year, the NPPA announces a change in the Wholesale Price Index (WPI) in accordance with the Drugs (Price Control) Order, 2013, or DPCO, 2013.
Subscribe
Login
0 Comments